Investor Presentaiton

Balance Sheet (NIS millions) (NIS millions) חברת החשמל Israel Electric Assets Current assets 12/31/2021 06/30/2021 06/30/2022 Liabilities and Equity 12/31/2021 06/30/2021 06/30/2022 Current liabilities Cash and cash equivalents 2,454 1,252 2,827 Credit from banks and other credit providers 5,425 3,682 6,863 Short term investments 332 357 357 Trade payables 2,786 2,932 3,211 Trade receivables for sales of electricity 4,290 4,406 4,391 Other current liabilities 1,238 1,329 1,520 Other current assets 665 801 930 Customer advances, net of work in progress 740 671 788 Inventory fuel 1,489 746 2,204 Provisions 686 721 692 Inventory stores 128 146 140 Liabillities of disposal groups classified as held for sale 146 Assets of disposal groups classified as 160 118 Total current liabilities 10,875 9,481 13,074 held for sale Total current assets 9,518 7,826 10,849 Non-current liabilities Debentures 24,488 25,255 26,766 Non-current assets Liabilities to banks 5,155 2,838 3,572 Liabilities with respect to other benefits after Inventory fuel 1,624 1,689 1,554 6,874 6,630 5,787 employment termination Long-term receivables 2,294 2,224 2,220 Deferred taxes, net 7,198 6,769 7,701 Investment in associates 4 4 11 Liability to the State of Israel 1,793 1,771 1,833 Assets with respect to benefits after 8,280 7,832 9,399 Lease liabilities 542 634 482 employment termination Fixed assets, net 59,123 Intangible assets, net 1,188 Total non-current assets 72,513 58,520 1,217 71,486 59,325 1,175 73,684 Other liabilities 592 572 485 Total non current liabilities 46,642 44,469 46,626 Equity 28,825 27,448 30,335 Debit balance of regulatory deferral accounts 8,581 7,037 10,038 Credit balances of regulatory deferral accounts and deferred taxes with respect to regulatory deferral accounts 4,270 4,951 4,536 Total assets and debit balance of regulatory deferral accounts 90,612 86,349 94,571 Total liabilities, equity and credit balance of regulatory deferral accounts 90,612 86,349 94,571 Source: IEC's Financial Statements for H1.2022 Investor Relations 39

View entire presentation